The global tyrosine kinase market is anticipated to witness a considerable CAGR of during the forecast period (2020-2026). The rising prevalence of cancer across the globe along with the growing R&D of new tyrosine kinase inhibitors is a key factor anticipated to drive the growth of the global tyrosine kinase market. According to the World Health Organization (WHO), cancer is the second leading cause of mortality across the globe which is responsible for around 9.6 million mortalities and accounted for 18.1 million new cases in 2018, globally. 1 in 5 men and 1 in 6 women, across the globe, develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease.
The tyrosine kinase inhibitors are given to the patients in order to stop the growth of cancer cells. Therefore, the high prevalence of different kinds of cancers is anticipated to create the demand for these drugs, which in turn is driving the growth of the tyrosine kinase inhibitor drugs across the globe.
OMR Global Recently Published Report on: https://www.omrglobal.com/industry-reports/tyrosine-kinase-market
Global Tyrosine Kinase Market Segmentation
By Type
- BCR-ABL Tyrosine Kinase Inhibitor
- Epidermal Growth Factor Receptor (EGFR)
- Vascular Endothelial Growth Factor Receptor (VEGFR)
- Anaplastic Lymphoma Kinase (ALK)
- Others
By Application
- Chronic Myeloid Leukemia (CML)
- Lung Cancer
- Breast Cancer
- Renal Cell Cancer
- Other
To Learn More About this Report Request a Free Sample Copy @ https://www.omrglobal.com/request-sample/tyrosine-kinase-market
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
